| Tretinoin | Approved Investigational Nutraceutical | KAT7 | 11143 |
downregulated | Tretinoin results in decreased expression of KAT7 mRNA | 17q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | KATNAL1 | 84056 |
upregulated | Tretinoin results in increased expression of KATNAL1 mRNA | 13q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KAZALD1 | 81621 |
downregulated | Tretinoin results in decreased expression of KAZALD1 mRNA | 10q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | KBTBD11 | 9920 |
downregulated | Tretinoin results in decreased expression of KBTBD11 mRNA | 8p23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNA2 | 3737 |
upregulated | Tretinoin results in increased expression of KCNA2 mRNA | 1p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNA5 | 3741 |
upregulated | Tretinoin results in increased expression of KCNA5 mRNA | 12p13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNAB1 | 7881 |
upregulated | Tretinoin results in increased expression of KCNAB1 mRNA | 3q25.31 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNAB2 | 8514 |
downregulated | Tretinoin results in decreased expression of KCNAB2 mRNA | 1p36.31 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNB1 | 3745 |
downregulated | Tretinoin results in decreased expression of KCNB1 mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNC1 | 3746 |
downregulated | Tretinoin results in decreased expression of KCNC1 mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNG1 | 3755 |
downregulated | Tretinoin results in decreased expression of KCNG1 mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNG1 | 3755 |
upregulated | Tretinoin results in increased expression of KCNG1 mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNH2 | 3757 |
downregulated | Tretinoin results in decreased expression of KCNH2 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNH5 | 27133 |
downregulated | Tretinoin results in decreased expression of KCNH5 mRNA | 14q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNIP4 | 80333 |
upregulated | Tretinoin results in increased expression of KCNIP4 mRNA | 4p15.31-p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNJ12 | 3768 |
downregulated | Tretinoin results in decreased expression of KCNJ12 mRNA | 17p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNJ13 | 3769 |
downregulated | Tretinoin results in decreased expression of KCNJ13 mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNJ16 | 3773 |
upregulated | Tretinoin results in increased expression of KCNJ16 mRNA | 17q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNJ2 | 3759 |
downregulated | Tretinoin results in decreased expression of KCNJ2 mRNA | 17q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNJ2 | 3759 |
upregulated | Tretinoin results in increased expression of KCNJ2 mRNA | 17q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNJ8 | 3764 |
downregulated | Tretinoin results in decreased expression of KCNJ8 mRNA | 12p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNK1 | 3775 |
downregulated | Tretinoin results in decreased expression of KCNK1 mRNA | 1q42.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNK1 | 3775 |
upregulated | Tretinoin results in increased expression of KCNK1 mRNA | 1q42.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNK12 | 56660 |
downregulated | Tretinoin results in decreased expression of KCNK12 mRNA | 2p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KCNK5 | 8645 |
downregulated | Tretinoin results in decreased expression of KCNK5 mRNA | 6p21.2 | |